NTRA
Natera Inc
NASDAQ: NTRA · HEALTHCARE · DIAGNOSTICS & RESEARCH
$194.75
-2.71% today
Updated 2026-04-29
Market cap
$27.81B
P/E ratio
—
P/S ratio
12.06x
EPS (TTM)
$-1.52
Dividend yield
—
52W range
$132 – $256
Volume
1.3M
Natera Inc (NTRA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $13.10M | $59.72M | $123.62M | $265.24M | $210.68M | $214.61M | $268.17M | $582.66M | $932.15M | $1.24B | $1.39B | $1.44B | $1.66B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $9.01M | $49.11M | $106.48M | $250.73M | $174.12M | $180.63M | $240.52M | $523.17M | $862.66M | $1.09B | $1.21B | $1.26B | $1.38B |
| Total liabilities | $138.90M | $231.23M | $294.96M | $80.47M | $104.20M | $189.20M | $236.01M | $303.94M | $445.92M | $583.18M | $688.73M | $676.37M | $465.31M |
| Current liabilities | $138.90M | $23.57M | $29.87M | $80.47M | $96.42M | $105.56M | $113.98M | $179.87M | $199.05M | $218.96M | $310.50M | $307.27M | $344.05M |
| Long-term debt | — | $22.46M | $24.47M | $0.00 | $0.00 | $73.06M | $73.36M | $73.66M | $202.49M | $280.39M | $281.65M | $282.94M | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-137.55M | $-174.66M | $-179.81M | $-250.08M | $-345.85M | $-446.38M | $-574.53M | $-699.17M | $-929.32M | $-1.39B | $-1.94B | $-2.38B | $-2.57B |
| Accounts receivable | $1.31M | $6.63M | $5.94M | $5.86M | $13.40M | $44.09M | $62.22M | $53.35M | $78.56M | $122.07M | $244.38M | $278.29M | $314.17M |
| Inventory | $1.60M | $10.65M | $11.54M | $8.09M | $6.41M | $9.00M | $13.63M | $12.39M | $20.03M | $26.91M | $35.41M | $40.76M | $44.74M |
| Goodwill | — | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |